A Stealth Drug Recall: Who Protects Consumers and Shareholders?

Autor/inn/en	Monseau, Susanna; Lasher, Nancy
Titel	A Stealth Drug Recall: Who Protects Consumers and Shareholders?
Quelle	In: Journal of Legal Studies Education, 32 (2015) 1, S.91-129 (39 Seiten) PDF als Volltext Verfügbarkeit
Sprache	englisch
Dokumenttyp	gedruckt; online; Zeitschriftenaufsatz
ISSN	0896-5811
Schlagwörter	Leitfaden; Unterricht; Lehrer; Drug Therapy; Pharmacy; Corporations; Governance; Legal Problems; Court Litigation; Case Studies; History; Public Agencies; Federal Regulation; Manufacturing; Advisory Committees; Teaching Methods; Ethics; Business Administration Education; Legal Education (Professions); Purchasing; Disclosure; Case Method (Teaching Technique) + Suchen Sie Ihr Suchwort? Lesson concept; Instruction; Unterrichtsentwurf; Unterrichtsprozess; Teacher; Teachers; Lehrerin; Lehrende; Apotheke; Unternehmen; Education; Educational policy; Financing; Steuerung; Bildung; Erziehung; Bildungspolitik; Finanzierung; Rechtsstreit; Case study; Fallstudie; Case Study; Geschichte; Geschichtsdarstellung; Öffentliche Einrichtung; Bundeskompetenz; Herstellung; Beratungsstelle; Teaching method; Lehrmethode; Unterrichtsmethode; Ethik; Juristischer Beruf; Beschaffungswesen; Kauf; Case method; Fallmethode
Abstract	In September 2010, William Weldon, chief executive officer (CEO) and chairman of Johnson & Johnson (J&J), was called to testify in front of the Committee on Oversight and Government Reform to explain the largest product recall in the 125-year history of the well-known pharmaceutical and consumer products company. This article presents a case study that uses the public testimony from two hearings before the Congressional Committee and other public documents to trace the story of the recalls and cover-ups related to Motrin and Tylenol products from 2008 to the Consent Decree in 2011. The case facts are followed by three additional sections: the first section provides background on the Food and Drug Administration (FDA) and the regulatory process for pharmaceuticals, including details of the standard of current good manufacturing practices; the second section provides a primer on corporate governance together with a discussion of J&J's board of directors and board committee structure; and the third comprises a teaching note. J&J is a well-known public company, familiar to most students. The authors have used this case with great success in legal environment and business ethics classes to stimulate discussion on ethics, corporate governance, and the role of regulatory agencies like the FDA. The authors provide students with the case facts and ask them to answer some of the questions before class so that class time can be used to discuss the issues. (ERIC).
Anmerkungen	Wiley-Blackwell. 350 Main Street, Malden, MA 02148. Tel: 800-835-6770; Tel: 781-388-8598; Fax: 781-388-8232; e-mail: cs-journals@wiley.com; Web site: http://www.wiley.com/WileyCDA
Erfasst von	ERIC (Education Resources Information Center), Washington, DC
Update	2020/1/01